These data shed light on how meningiomas can grow despite expression of Merlin, a canonical tumor suppressor, and provide a mechanistic basis for meningioma ADC, which has been previously proposed as a non-invasive biomarker of meningioma outcomes in humans41. This evidence concerns the gene NF2 and meningioma.